MicroRNA-20a constrains p300-driven myocardial angiogenic transcription by direct targeting of p300

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Shehadeh, Lina A ^a   Sharma, Salil ^a   Pessanha, Mônica ^a   Wei, Jian Qin ^a   Liu, Jing ^a   Yuan, Huijun ^a   Rodrigues, Claudia O ^a   Scherr, Michaela ^b   Tsinoremas, Nicholas F ^a   Bishopric, Nanette H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; E1A ASSOCIATED P300 PROTEIN; MICRORNA; MICRORNA 17; MICRORNA 20A; UNCLASSIFIED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSDUCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; TRANSGENE; UPREGULATION; WILD TYPE;

ANGIOGENIC PROTEINS; ANIMALS; CELLS, CULTURED; CORONARY VESSELS; E1A-ASSOCIATED P300 PROTEIN; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RNA INTERFERENCE;

EID: 84893165979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079133     Document Type: Article

References (49)

1. Hudlicka O, Brown M, Egginton S (1992) Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369-417.
2. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, et al. (2001) A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98: 5780-5785.
3. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, et al. (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111: 2073-2085.
4. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H (2005) Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci 12: 409-420.
5. Anversa P, Olivetti G, Melissari M, Loud AV (1979) Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis. Lab Invest 40: 341-349.
6. Marcus ML, Harrison DG, Chilian WM, Koyanagi S, Inou T, et al. (1987) Alterations in the coronary circulation in hypertrophied ventricles. Circulation 75: I19-25.
7. Tomanek RJ (1990) Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 15: 528-533.
8. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R (1992) Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86: 38-46.
9. Choi YH, Cowan DB, Nathan M, Poutias D, Stamm C, et al. (2008) Myocardial hypertrophy overrides the angiogenic response to hypoxia. PLoS One 3: e4042.
10. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, et al. (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95: 187-195.
11. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, et al. (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118.
12. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, et al. (2007) p53- induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446: 444-448.
13. Wei JQ, Shehadeh LA, Mitrani JM, Pessanha M, Slepak TI, et al. (2008) Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118: 934-946.
14. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
15. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
16. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, et al. (2007) Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 35: e149.
17. Kienstra KA, Freysdottir D, Gonzales NM, Hirschi KK (2007) Murine neonatal intravascular injections: modeling newborn disease. J Am Assoc Lab Anim Sci 46: 50-54.
18. Sharma S, Liu J, Wei J, Yuan H, Zhang T, et al. (2012) Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO Mol Med 4: 617-632.
19. Pessanha MG, Mandarim-de-Lacerda CA (2000) Influence of the chronic nitric oxide synthesis inhibition on cardiomyocytes number. Virchows Arch 437: 667-674.
20. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
21. Lee TI, Johnstone SE, Young RA (2006) Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 1: 729-748.
22. Bishopric NH, Kedes L (1991) Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy. Proc Natl Acad Sci USA 88: 2132-2136.
23. Slepak T, Webster KA, Zang J, Prentice H, O'Dowd A, et al. (2001) Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D. J Biol Chem 276: 7575-7585.
24. Rodrigues CO, Shehadeh LA, Hoosien M, Otero V, Chopra I, et al. (2011) Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells. PLoS One 6: e24013.
25. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, et al. (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104: 170-178, 176p following 178.
26. Hua Z, Lv Q, Ye W, Wong CK, Cai G, et al. (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116.
27. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, et al. (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68: 5540-5545.
28. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, et al. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361-372.
29. Anversa P, Loud AV, Levicky V, Guideri G (1985) Left ventricular failure induced by myocardial infarction. II. Tissue morphometry. Am J Physiol 248: H883-889.
30. Woods K, Thomson JM, Hammond SM (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282: 2130-2134.
31. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
32. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, et al. (2007) An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143.
33. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, et al. (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 105: 14082-14087.
34. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-524.
35. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, et al. (2008) The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118: 868-878.
36. Frank D, Gantenberg J, Boomgaarden I, Kuhn C, Will R, et al. (2012) MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3. J Mol Cell Cardiol 52: 711-717.
37. Chen J, Huang ZP, Seok H, Ding J, Kataoka M, et al. (2013) mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 112: 1557-66.
38. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, et al. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228.
39. Tillmanns J, Rota M, Hosoda T, Misao Y, Esposito G, et al. (2008) Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A 105: 1668-1673.
40. Bearzi C, Leri A, Lo Monaco F, Rota M, Gonzalez A, et al. (2009) Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A 106: 15885-15890.
41. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115: 4944-4950.
42. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103: 9136-9141.
43. Hossain A, Kuo MT, Saunders GF (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201.
44. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
45. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, et al. (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
46. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, et al. (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
47. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
48. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579.
49. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.